Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)

NCT00965809 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Posttraumatic Stress Disorders

Interventions

DRUG: Tetrahydrocannabinol
OTHER: Placebo

Sponsor

Hadassah Medical Organization